Hemophagocytic lymphohistiocytosis‐like toxicity (carHLH) after CD19‐specific CAR T‐cell therapyMelissa Hines, Aimee C. Talleur, Camille Keenan et al.|British Journal of Haematology|2021Cited by 122
Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputationSvea Böhm, Stephan Ehl, Martina Ahlmann et al.|Blood|2023Cited by 41